Skip to main content
. 2024 Aug 26;15:1443327. doi: 10.3389/fmicb.2024.1443327

Table 2.

Chemical characterization of lipopeptides from Bacillus and Paenibacillus species by UPLC-QTOF-MS: a = LIS04; b = CT02; c = LIS05; d = IM14.

Peak RT (min) Compounds CFS* Molecular formula Ion m/z Error (ppm) Fragment ions m/z References
1 10.29 Lipopeptide ND*-1 a C47H63N8O7 851.4822 [M + H]+ 0.2 437; 409
2 12.44 Iturin A2 c,d C48H74N12O14 1,043.5519 [M + H]+ −0.7 299; 801; 915 Ye et al., 2012
3 12.95 Lipopeptide ND-2 a C47H75N10O11 955.5617 [M + 2H]+ −0.9 478; 353
4 13.25 Iturin A3–A5 d C49H76N12O14 1,057.5995 1.2 Souza et al., 2018
5 13.59 C14 Fengycin A b, c, d C70H107N12O20 718.3788 [M + 2H]+ 1.7 966; 1,080 Souza et al., 2018; Villegas-Escobar et al., 2018
6 13.79 C16 Fengycin A b C72H114N12O20 741.3965 [M + 2H]+ 3.9 966; 1,080 Ma et al., 2016
7 13.94 C16Fengycin A b C72H114N12O20 741.3937 [M + 2H]+ 0.1 966; 1,080 Ma et al., 2016
8 14.06 C15 Fengycin A b, d C71H108N12O20 725.4003 [M + 2H]+ 2.3 966; 1,080 Souza et al., 2018; Villegas-Escobar et al., 2018
9 14.33 C15Fengycin A d C71H108N12O20 725.3876[M + 2H]+ 0.7 966; 1,080 Souza et al., 2018; Villegas-Escobar et al., 2018
10 14.44 C15Fengycin A b, c, d C71H108N12O20 725.3986 [M + 2H]+ −3.7 966; 1,080 Souza et al., 2018; Villegas-Escobar et al., 2018
11 14.60 Lipopeptide ND-3 a C25H44N5O4 478.3410[M + H]+ 3.6 376, 162
12 14.79 C16Fengycin A b, c, d C72H110N12O20 732.3915 [M + 2H]+ −2.3 966; 1,080 Souza et al., 2018; Villegas-Escobar et al., 2018
13 15.20 C17 Fengycin A b, c, d C72H110N12O20 739.3990 [M + 2H]+ 3.9 966; 1,080 Souza et al., 2018; Villegas-Escobar et al., 2018
14 15.24 C16 Fengycin B b, c, d C74H114N12O20 746.4111 [M + 2H]+ 2.9 966; 1,080 Souza et al., 2018; Villegas-Escobar et al., 2018
15 15.79 C17 Fengycin B b, c C75H116N12O20 753.4147 [M + 2H]+ 3.6 994; 1,180 Souza et al., 2018; Villegas-Escobar et al., 2018
16 16.02 C16 Fengycin B b, c C74H114N12O20 746.4069 [M + 2H]+ −2.0 994 Souza et al., 2018; Villegas-Escobar et al., 2018
17 16.14 C17 Fengycin A b C72H110N12O20 739.4049 [M + 2H]+ −2.3 966; 1080 Souza et al., 2018; Villegas-Escobar et al., 2018
18 16.42 C18Fengycin B b, c, d C76H119N12O20 760.4244[M + 2H]+ 1.0 994; 1022; 1180 Ma et al., 2016
19 17.60 Lipopeptide ND-4 a C56H98N16O13 602.4215[M + 2H]+ 2.3 562; 662
20 18.59 Lipopeptide ND-5 a C17H21N2O7 365.1349[M + H]+ 1.7 163, 105
21 21.49 C14 Surfactin b, c C45H97N7O19 1,040.6917 −0.1 685; 909; 1022 Ma et al., 2016
22 22.35 C12 Surfactin b, c C43H91N7O18 994.6500 0.1 685; 873; 976 Tang et al., 2010; Ma et al., 2016
23 22.61 Surfactin b, c C56H91N7O12 1,054.6807 [M + H]+ 0.3 441; 554 Ma et al., 2016
24 22.98 Surfactin b, c C51H89N7O13 1,008.6611 1.4 455; 667; 895 Souza et al., 2018
25 23.58 Surfactin b, c, d C51H89N7O13 1,008.6600 0.3 455; 667; 895 Souza et al., 2018
26 23.79 Surfactin b, c, d C52H91N7O13 1,022.6726 −2.6 582; 796; 909 Souza et al., 2018
27 23.97 Surfactin b, c, d C52H91N7O13 1,022.6714 −3.8 582; 796; 909 Souza et al., 2018
28 24.28 Surfactin c C51H89N7O13 1,008.6581 [M + H]+ −1.6 455; 667; 895 Souza et al., 2018
29 24.51 Surfactin b, c, d C53H93N7O13 1,036.6929 1.8 441; 685; 923 Souza et al., 2018
30 24.88 Surfactin c C53H93N7O13 1,036.6910 [M + H]+ 0.8 441; 685; 923 Souza et al., 2018

ND. not determined.

*Cell-free supernatant.